Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:524-525 (4 September), doi:10.1136/bmj.329.7465.524
Better vaccines are needed if vaccination is to be made compulsory
| The first 150 words of the full text of this article appear below. |
Taken at face value the use of vaccines to prevent the effects of serious infections caused by a terrorist attack appears a sensible policy. In 1997 the United States Department of Defense initiated the compulsory anthrax vaccine immunisation programme to immunise 2.4m military personnel.1 In December 2002 a similar programme, also involving civilians, was started against smallpox. In the first five and half months the Department of Defense administered 450 293 doses of smallpox vaccine.2 United States military personnel engaged in military operations in Iraq are immunised against smallpox and anthrax. As in any vaccination campaign, the incidence of the target disease and the characteristics of available vaccines are two key elements in decision making.
Naturally occurring anthrax is a rare disease. It occurs mostly in cutaneous form among those exposed to animal products (such as hides) and causes a rare and rapidly fatalif untreatedrespiratory illness (inhalation anthrax). Inhalation
Tom Jefferson, coordinator
Cochrane Vaccines Field, Via Adige 28a, 00061 Anguillara Sabazia, Rome, Italy (Toj1@aol.com)
Read all Rapid Responses